Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.42%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
87.26 Down 1.55(1.75%) 4:00PM EDT
|After Hours : 87.00 Down 0.26 (0.30%) 5:04PM EDT
Prev Close:88.81
Open:88.04
Bid:87.00 x 100
Ask:89.00 x 1900
1y Target Est:114.68
Beta:1.57024
Earnings Date:Aug 1 - Aug 5 (Est.)
Day's Range:86.21 - 88.39
52wk Range:62.12 - 151.75
Volume:877,569
Avg Vol (3m):1,565,960
Market Cap:14.16B
P/E (ttm):N/A
EPS (ttm):-1.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 1.75%14.16B
FOLDDown 0.99%893.16M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.20
Quarterly EPS Est (Jun-16) :-0.50
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback